Wilmer Cutler Pickering Hale and Dorr has advised Biogen. Biogen Inc. (Nasdaq: BIIB) announced that it has entered into a definitive agreement to acquire RayThera Inc.,...
Biogen to Acquire RayThera for Up to $1 Billion
Climb Bio Completes $110 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr has advised Climb Bio, Inc. on the deal. Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company, has announced the...
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Transaction Valued Up to $285 Million
Wilmer Cutler Pickering Hale and Dorr has advised Mersana Therapeutics. Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One...
Morgan Stanley Acquires EquityZen
WilmerHale and Sidley Austin have advised EquityZen, and Morgan, Lewis & Bockius LLP has advised Morgan Stanley. Morgan Stanley has announced its agreement to acquire EquityZen,...
SAB BIO Raises $175 Million in Oversubscribed Private Placement
Dentons US LLP has advised SAB Biotherapeutics, Inc. on the transaction, and WilmerHale has advised RA Capital Management as lead investor. SAB BIO (Nasdaq: SABS), a...
Eliem Therapeutics’ Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
Wonder Group’s $103 Million Acquisition of Blue Apron
Fenwick & West represented Wonder Group in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented Blue Apron Holdings. Wonder Group (“Wonder”) announced that it has...
Blue Apron’s Transaction with FreshRealm
WilmerHale represented Blue Apron in the transaction. Blue Apron (NYSE: APRN), an American ingredient-and-recipe meal kit company, announced the signing and closing of a transaction with...
Gemini Therapeutics’ Combination with Disc Medicine
Wilmer Cutler Pickering Hale and Dorr advised Gemini, while Goodwin Procter advised Disc Medicine. Fried, Frank, Harris, Shriver & Jacobson acted as counsel to SVB Securities...
Acquco’s $160 Million Series A Round
Wilmer Cutler Pickering Hale and Dorr advised Acquco on the deal. Acquco, a platform focused on acquiring third-party sellers on Amazon, announced that it has closed...
Amplitude Healthcare’s Business Combination with Jasper Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics. Amplitude Healthcare Corporation (Nasdaq: AMHC), a special...
Relay Therapeutics’ Acquisition of ZebiAI Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised ZebiAI Therapeutics, Inc. on the deal. ZebiAI Therapeutics, Inc., an artificial intelligence company that pioneers the application of machine...